Portfolio
Portfolio

Flowmedica

Novel, proprietary, minimally invasive intravascular systems for implementing targeted renal therapy.

Flowmedica has developed novel, proprietary, minimally invasive intravascular systems for implementing targeted renal therapy. Three infusion systems have been developed and provide an alternative to the standard delivery methods of systemic intravenous infusion to address kidney dysfunction related to a number of diseases.

The assets of the company were sold to AngioDynamics in 2009.

  • History Other